Aspartate β-Hydroxylase Serves as a Prognostic Biomarker for Neoadjuvant Chemotherapy in Gastric Cancer

Neoadjuvant chemotherapy (NACT) has been established as being an effective treatment for advanced gastric cancer (GC), while the predictive biomarker of NACT efficacy remains under investigation. Aspartate β-hydroxylase (ASPH) represents an attractive target which is a highly conserved transmembrane...

Descripción completa

Detalles Bibliográficos
Autores principales: Gan, Xuejun, Li, Shen, Wang, Yiding, Du, Hong, Hu, Ying, Xing, Xiaofang, Cheng, Xiaojing, Yan, Yan, Li, Ziyu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10053938/
https://www.ncbi.nlm.nih.gov/pubmed/36982561
http://dx.doi.org/10.3390/ijms24065482

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10053938/
https://www.ncbi.nlm.nih.gov/pubmed/36982561
http://dx.doi.org/10.3390/ijms24065482

Ejemplares similares